Mark Mirochnick, MD is Professor of Pediatrics and Chief of the Division of Neonatology at Boston University School of Medicine/Boston Medical Center. He has extensive experience in clinical trials investigating the clinical pharmacology of antiretrovirals in infants, children and pregnant women. He has served as protocol chair, investigator and/or protocol pharmacologist on more than 25 perinatal and pediatric HIV protocols in the US, Africa, South America and Asia sponsored by NIAID, NICHD and CDC. He currently serves as co-chair of the US Perinatal HIV Guidelines Committee and is a member of the US Pediatric HIV Guidelines Committee and the WHO Pediatric Antiretroviral Working Group.
Conflict of Interest: Dr. Mirochnick has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Merck, ViiV, Gilead, ReViral.